cro.directory
← Compare landing

Alturas Analytics vs Selvita

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/alturasanalytics/selvita

CategoryAlturas AnalyticsSelvita
Listed sitecrocro
SummaryGLP-compliant bioanalytical CRO specializing in LC-MS/MS solutions for preclinical and clinical research, IND submissions, and new drug applications.Selvita is an integrated drug discovery and development service provider offering comprehensive solutions from target validation through preclinical candidate nomination and clinical manufacturing, with expertise in small molecules, antibodies, and protein degraders.
Services
  • LC-MS Bioanalysis (Small Molecule)
  • Bioanalysis
  • In Vivo PK / PD Studies
  • Preclinical In Vivo Studies
  • US FDA Regulatory Strategy
  • Regulatory Affairs
  • Bioinformatics & Data Science
  • Computational & In-Silico Drug Discovery
  • Medicinal Chemistry
  • High-Throughput Screening
  • Target Identification & Validation
  • Discovery Research
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Preclinical In Vitro Studies
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Regulatory Affairs
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Protein Engineering
  • Microbiology Services
ModalitiesData not yet provided.
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Peptide
IndicationsData not yet provided.
  • Oncology
  • Respiratory
  • Neurology
  • Metabolic
  • Infectious Disease
  • Gastroenterology
  • Immunology
Locations
  • Headquarters, Moscow, Idaho, United States
Data not yet provided.
Certifications
  • GLP · Identifier: GLP compliant
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.